Results 101 to 110 of about 3,459 (164)

Resistencia a los antimicrobianos

, 2016
La resistencia antimicrobiana es un problema de carácter mundial que afecta a todos los grupos poblacionales, especialmente a los niños. La principal causa de aparición de la resistencia antimicrobiana es el uso irracional de estos medicamentos. EL CDC estima que 75% del consumo de antimicrobianos se presenta en la comunidad.
openaire   +1 more source

Nursing care in primary health care to tackle antimicrobial resistance in pregnant women with urinary tract infections. [PDF]

Rev Esc Enferm USP
Figueiredo JL, Padoveze MC.
europepmc   +1 more source

Analysis of omission of antimicrobial doses in Intensive Care Units. [PDF]

Rev Bras Enferm
Machado IR, Henrique DM, Camerini FG, Paula VG, Fassarella CS, Mello LRG.   +5 more
europepmc   +1 more source

Double-carbapenemase-producing Enterobacteriaceae: complete genome sequencing of isolates from hospitals in Paraguay, 2021. [PDF]

Rev Peru Med Exp Salud Publica
Melgarejo Touchet N, Weiler N, Busignani S, Orrego V, Duarte MJ, Martínez J, Dunjo P, Martínez Mora M, Kawabata A, Irala J, Brítez M, Escobar F, Gonzalez F, Riquelme C, Soilan B.   +14 more
europepmc   +1 more source

Editorial: Multidrug resistant bacteria: new therapeutic approaches for a challenging problem. [PDF]

Front Pharmacol
Fernández GC, Smani Y, Gómez SA.
europepmc   +1 more source

[Antimicrobial stewardship program in an Intensive Care Unit: A retrospective observational analysis of the results 15 months after its implementation]. [PDF]

Rev Esp Quimioter, 2023
Pérez-Torres D, Tamayo-Lomas LM, Domínguez-Gil González M, Almendros-Muñoz R, Sacristán-Salgado MA, González-González E, Berezo-García JA, Díaz-Rodríguez C, Canas-Pérez I, Lorenzo-Vidal B, Eiros-Bouza JM.   +10 more
europepmc   +1 more source

[Epidemiological characteristics of patients with carbapenemase-producing NDM Enterobacterales isolates in a high-complexity hospital]. [PDF]

Rev Esp Quimioter
Artiles-León CM, Rodríguez-Restrepo S, Torres-Jiménez IA, de Las Delicias Quintana-Estellés M, Viedma-Moreno E, Arrazola-Martínez P, Jaén-Herreros F, Sanz-Gallardo I, Suárez-García E, Craviotto-Vallejo A, de Miguel-García S.   +10 more
europepmc   +1 more source

<i>In vitro</i> activity of cefiderocol against ESBL-producing and carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

JAC Antimicrob Resist
Egoávil-Espejo R, Ymaña B, Oporto-Llerena R, Navarro D, Huerto-Huánuco R, Salvador-Luján G, Ortiz-Gómez T, Pinedo-Bardales M, Palomino-Kobayashi LA, Gómez AC, Castillo AK, Gonzales P, Valera-Krumdieck C, Soza G, Zapata-Cachay C, Riveros M, Pons MJ, Ruiz J.   +17 more
europepmc   +1 more source

Epidemiological characteristics of antimicrobial use in Primary Care in Spain: a nationwide study. [PDF]

Rev Esp Quimioter
Sánchez-Herrero H, Solaz-García Á, Pinilla-González A, Martínez-Sánchez EV, Santágueda-Balader P, Cernada-Badía M.   +5 more
europepmc   +1 more source

Antimicrobial resistance interventions in Latin America and the Caribbean: a scoping review of reported interventions between 2018-2024. [PDF]

Antimicrob Resist Infect Control
Gozzer E, Becerra-Chauca N, Abba-Aji M, Wirtz VJ, Cordoba G, Canchihuamán F, Nagassar RP, Yañez-Diaz S, Brou PS, Delgado-Flores CJ, Fazaludeen Koya S.   +10 more
europepmc   +1 more source